Membership
NLA Education and Training
Practice Tools
LipidSpin
JCL
Find a Member

News


February 11, 2021

FDA Approves First-in-class Evkeeza™ (evinacumab-dgnb) for Patients with Ultra-rare Inherited Form of High Cholesterol

Regeneron Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) approved EvkeezaTM...

Read More...

January 15, 2021

NLA & Chapter Nomination Windows Open Through February 28, 2021

The window for nominations to NLA and Chapter leadershp positions is now open through February 28, 2021. Open positions...

Read More...

January 6, 2021

National Lipid Association Achieves New Six Year Term for Joint Accreditation

JACKSONVILLE, Fla. – (January 6, 2021) -- The National Lipid Association (NLA) is proud to announce that it has...

Read More...

December 12, 2020

NLA Releases Official Scientific Statement on CAC Scoring

The NLA today announced the release of its official scientific statement on CAC scoring to guide prevention of ASCVD.

Read More...

December 10, 2020

National Lipid Association Announces Late-Breaking Abstract Presentations at NLA 2020 Virtual Scientific Sessions

National Lipid Association Announces Late-Breaking Abstract Presentations at NLA 2020 Virtual Scientific Sessions...

Read More...